Industry News
Survival results from phase III BREAK-3 study of Tafinlar® (dabrafenib) in patients with BRAF V600E-mutant metastatic melanoma
Oct 01, 2014
GSK has announced updated results for Tafinlar® (dabrafenib) from a planned analysis of the phase III BREAK-3 study in 250 patients with BRAF V600E mutant metastatic melanoma. Read More
Genetic test would help 'cut bowel cancer spread'
Oct 01, 2014
Screening families of patients with bowel cancer for a genetic condition would cut their risk of developing bowel, womb, and ovarian cancers, new research has found. Read More
Targeted treatment could halt womb cancer growth
Oct 01, 2014
A drug which targets a key gene fault could halt an aggressive womb cancer and shrink tumours, according to research published in the British Journal of Cancer. Read More
New imaging technique could revolutionise how children with neuroblastoma are diagnosed and treated
Oct 01, 2014
Cancer Research UK's Centre for Drug Development (CDD), in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, has announced... Read More
Study: tumor BRACAnalysis CDx identifies 44 percent more candidates for PARP therapy
Oct 01, 2014
Myriad Genetics, Inc. has announced that its Tumor BRACAnalysis CDx™ companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in women... Read More
Immunotherapy could stop resistance to radiotherapy
Oct 01, 2014
Treating cancers with immunotherapy and radiotherapy at the same time could stop them from becoming resistant to treatment, according to a study published in Cancer Research. Read More
Thyroid cancer: additional new subgroup analyses for Phase III SELECT trial
Oct 01, 2014
A new analysis from the Phase III SELECT (Study of (E7080) LEnvatinib in Differentiated Cancer of the Thyroid) trial of lenvatinib (E7080) in the treatment of radioiodine-refractory differentiated... Read More
Breast density: over 700,000 UK women living with 'hidden' breast cancer risk
Oct 01, 2014
Risk Determination and Prevention of Breast Cancer[1], published in the journal Breast Cancer Research, identifies the critical gaps that must be addressed if we are to reverse the increase in... Read More
Lungs from donors who die from drowning, asphyxiation may be safe for transplant
Oct 01, 2014
Researchers claim transplanting lungs from donors who die from drowning or asphyxiation appears to be safe and may be a way of 'expanding the donor pool.' Read More
Progression-free survival for meta or recurrent cervical cancer improved by adding cediranib to chemo
Oct 01, 2014
For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and... Read More
Previous Page Next Page